Study shows GLP-1 receptor agonists and GIP drugs reduce alcohol and opioid addiction by 50% and 40%, respectively.

A study published in the journal Addiction indicates that weight loss and diabetes medications, specifically GLP-1 receptor agonists like Ozempic and GIP drugs like Mounjaro, may help reduce alcohol and opioid addiction. Researchers found a 50% decrease in alcohol intoxication and a 40% reduction in opioid overdose among users of these medications. The findings suggest further investigation into their potential as treatment options for substance use disorders is warranted.

October 17, 2024
99 Articles